Non-invasive markers of liver fibrosis such as FIB-4 index, NFS and TEM (42), and serum biomarkers such as ALT, AST and GGT have been associated with NAFLD and NASH (43, 44). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.